| scholarly article | Q13442814 |
| P50 | author | Jean-Pierre Changeux | Q910163 |
| Billy R Martin | Q60467790 | ||
| P2093 | author name string | M Imad Damaj | |
| Sharon Brown | |||
| Carrie L Walters | |||
| P2860 | cites work | In vivo pharmacological effects of dihydro-beta-erythroidine, a nicotinic antagonist, in mice | Q45083493 |
| Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors | Q46586967 | ||
| Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum | Q48434978 | ||
| Binding of the nicotinic cholinergic antagonist, dihydro-beta-erythroidine, to rat brain tissue | Q48594761 | ||
| A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homo-oligomeric channel blocked by α-BTX | Q48856964 | ||
| Multiple determinants of dihydro-beta-erythroidine sensitivity on rat neuronal nicotinic receptor alpha subunits | Q48974722 | ||
| Long-term potentiation of excitatory inputs to brain reward areas by nicotine. | Q51381056 | ||
| Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. | Q51627333 | ||
| Blockade of nicotine self-administration with nicotinic antagonists in rats. | Q52177843 | ||
| Pharmacologic characterization of nicotine-induced conditioned place preference. | Q52268923 | ||
| A sensitive technique for the detection of the alpha 7 neuronal nicotinic acetylcholine receptor antagonist, methyllycaconitine, in rat plasma and brain. | Q52547543 | ||
| Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine. | Q27863674 | ||
| Pharmacological characterization of nicotine-induced seizures in mice | Q28376560 | ||
| Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors | Q28505103 | ||
| Nicotine receptor inactivation decreases sensitivity to cocaine | Q28513615 | ||
| Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei | Q28564628 | ||
| Rat nicotinic acetylcholine receptor alpha2beta2 channels: comparison of functional properties with alpha4beta2 channels in Xenopus oocytes | Q28570726 | ||
| Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine | Q28589593 | ||
| Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents | Q28592111 | ||
| Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain | Q28594028 | ||
| Fear conditioning and latent inhibition in mice lacking the high affinity subclass of nicotinic acetylcholine receptors in the brain | Q28594253 | ||
| Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats | Q29619737 | ||
| Conditioned place preference: what does it add to our preclinical understanding of drug reward? | Q34188090 | ||
| Achieving tobacco cessation: current status, current problems, future possibilities. | Q34858773 | ||
| The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat. | Q43788914 | ||
| Lesions of the tegmental pedunculopontine nucleus block the rewarding effects and reveal the aversive effects of nicotine in the ventral tegmental area. | Q44156202 | ||
| Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area | Q44295864 | ||
| Characterization of spontaneous and precipitated nicotine withdrawal in the mouse | Q44582589 | ||
| P433 | issue | 3-4 | |
| P304 | page(s) | 339-344 | |
| P577 | publication date | 2006-01-14 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice | |
| P478 | volume | 184 |
| Q38851564 | A threshold model for opposing actions of acetylcholine on reward behavior: Molecular mechanisms and implications for treatment of substance abuse disorders. |
| Q34172963 | A transcriptional regulatory element critical for CHRNB4 promoter activity in vivo |
| Q44977420 | Acute behavioral effects of nicotine in male and female HINT1 knockout mice |
| Q35203630 | Acute nicotine administration increases BOLD fMRI signal in brain regions involved in reward signaling and compulsive drug intake in rats |
| Q38624524 | Allosteric modulation of α4β2* nicotinic acetylcholine receptors: Desformylflustrabromine potentiates antiallodynic response of nicotine in a mouse model of neuropathic pain |
| Q35837691 | Alpha7 nicotinic acetylcholine receptors modulate motivation to self-administer nicotine: implications for smoking and schizophrenia |
| Q48911423 | Alpha7-nicotinic receptors modulate nicotine-induced reinforcement and extracellular dopamine outflow in the mesolimbic system in mice. |
| Q35631485 | Anxiolytic-like and anxiogenic-like effects of nicotine are regulated via diverse action at β2*nicotinic acetylcholine receptors |
| Q28534828 | Behavioral and molecular analysis of nicotine-conditioned place preference in zebrafish |
| Q41891396 | Beta 2 subunit-containing nicotinic receptors mediate acute nicotine-induced activation of calcium/calmodulin-dependent protein kinase II-dependent pathways in vivo |
| Q30491573 | Beta2 subunit containing acetylcholine receptors mediate nicotine withdrawal deficits in the acquisition of contextual fear conditioning |
| Q37164812 | Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies |
| Q36349942 | Bupropion and its main metabolite reverse nicotine chronic tolerance in the mouse |
| Q37247103 | Cellular events in nicotine addiction |
| Q34058860 | Chrna4 A529 knock-in mice exhibit altered nicotine sensitivity |
| Q30570256 | Cocaine-associated odor cue re-exposure increases blood oxygenation level dependent signal in memory and reward regions of the maternal rat brain |
| Q34360535 | Conditioned place preference and self-administration induced by nicotine in adolescent and adult rats |
| Q35181132 | Contributions of β2 subunit-containing nAChRs to chronic nicotine-induced alterations in cognitive flexibility in mice |
| Q24650892 | Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration |
| Q37535489 | Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: recent progress and emerging open questions |
| Q35647302 | Differential roles of α6β2* and α4β2* neuronal nicotinic receptors in nicotine- and cocaine-conditioned reward in mice. |
| Q38204497 | Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation |
| Q30490291 | Dopamine enables in vivo synaptic plasticity associated with the addictive drug nicotine |
| Q30597187 | Dual role of nicotine in addiction and cognition: a review of neuroimaging studies in humans |
| Q52597124 | Effect of nicotine and alpha-7 nicotinic modulators on visceral pain-induced conditioned place aversion in mice. |
| Q33835737 | Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse |
| Q37351302 | Effects of blockade of α4β2 and α7 nicotinic acetylcholine receptors on cue-induced reinstatement of nicotine-seeking behaviour in rats |
| Q42365798 | Effects of nicotine in combination with drugs described as positive allosteric nicotinic acetylcholine receptor modulators in vitro: discriminative stimulus and hypothermic effects in mice. |
| Q37291940 | Effects of the beta-lactam antibiotic ceftriaxone on nicotine withdrawal and nicotine-induced reinstatement of preference in mice |
| Q36298187 | Effects of the specific α4β2 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice |
| Q26853457 | Genetic matters: thirty years of progress using mouse models in nicotinic research |
| Q30485478 | Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research |
| Q37573968 | Genetic variation within the Chrna7 gene modulates nicotine reward-like phenotypes in mice |
| Q36453486 | Genetics of nicotine dependence and pharmacotherapy |
| Q30491854 | Genetics of nicotinic acetylcholine receptors: Relevance to nicotine addiction |
| Q28265155 | Genetics of smoking and depression |
| Q30480193 | Hippocampal nAChRs mediate nicotine withdrawal-related learning deficits |
| Q37520732 | Hypocretin mechanisms in nicotine addiction: evidence and speculation |
| Q64915913 | Inhibition of alpha7 nicotinic receptors in the ventral hippocampus selectively attenuates reinstatement of morphine-conditioned place preference and associated changes in AMPA receptor binding. |
| Q37146387 | Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats |
| Q30448803 | Insights into the neurobiology of the nicotinic cholinergic system and nicotine addiction from mice expressing nicotinic receptors harboring gain-of-function mutations |
| Q35694111 | Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapies |
| Q45054305 | In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence |
| Q37166530 | Localized low-level re-expression of high-affinity mesolimbic nicotinic acetylcholine receptors restores nicotine-induced locomotion but not place conditioning. |
| Q36105359 | Long-term nicotine exposure depresses dopamine release in nonhuman primate nucleus accumbens |
| Q28484969 | Low dose nicotine and antagonism of β2 subunit containing nicotinic acetylcholine receptors have similar effects on affective behavior in mice |
| Q56529261 | Manipulating midbrain dopamine neurons and reward-related behaviors with light-controllable nicotinic acetylcholine receptors |
| Q30497524 | Mechanisms involved in systemic nicotine-induced glutamatergic synaptic plasticity on dopamine neurons in the ventral tegmental area |
| Q46364764 | Medication-related pharmacological manipulations of nicotine self-administration in the rat maintained on fixed- and progressive-ratio schedules of reinforcement |
| Q30489625 | Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine |
| Q26851972 | Molecular mechanisms underlying behaviors related to nicotine addiction |
| Q37327392 | Molecular mechanisms underlying the motivational effects of nicotine |
| Q27008063 | Molecules and circuits involved in nicotine addiction: The many faces of smoking |
| Q90603824 | More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder |
| Q30432964 | Mouse models for studying genetic influences on factors determining smoking cessation success in humans |
| Q34012381 | Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system |
| Q36137598 | Neuronal nicotinic acetylcholine receptors: neuroplastic changes underlying alcohol and nicotine addictions |
| Q39059946 | Neuropeptide systems and new treatments for nicotine addiction |
| Q88960570 | New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice |
| Q37756527 | Nicotine addiction and nicotinic receptors: lessons from genetically modified mice |
| Q36920049 | Nicotine enhances context learning but not context-shock associative learning |
| Q35031943 | Nicotine enhances the locomotor stimulating but not the conditioned rewarding effect of ethanol in DBA/2J mice |
| Q28728978 | Nicotine receptor subtype-specific effects on auditory evoked oscillations and potentials |
| Q30485318 | Nicotine withdrawal disrupts new contextual learning |
| Q45032449 | Nicotine-induced enhancement of responding for conditioned reinforcement in rats: role of prior nicotine exposure and α4β2 nicotinic receptors |
| Q47921424 | Nicotine-motivated behavior in Caenorhabditis elegans requires the nicotinic acetylcholine receptor subunits acr-5 and acr-15. |
| Q36851620 | Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation |
| Q43099250 | Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement. |
| Q34631254 | Nicotinic alpha 7 receptors as a new target for treatment of cannabis abuse |
| Q35966896 | Nicotinic receptor contributions to smoking: insights from human studies and animal models |
| Q30451446 | Nicotinic receptors in the dorsal and ventral hippocampus differentially modulate contextual fear conditioning |
| Q37055419 | Nominal association with CHRNA4 variants and nicotine dependence |
| Q37259323 | Nucleus accumbens CREB activity is necessary for nicotine conditioned place preference |
| Q35054656 | Null mutation of the β2 nicotinic acetylcholine receptor subunit attenuates nicotine withdrawal-induced anhedonia in mice |
| Q50148077 | Optically dissecting brain nicotinic receptor function with photo-controllable designer receptors |
| Q37395740 | Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes |
| Q37230901 | Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration |
| Q27021772 | Preclinical evidence that activation of mesolimbic alpha 6 subunit containing nicotinic acetylcholine receptors supports nicotine addiction phenotype |
| Q35229091 | Protein kinase C epsilon modulates nicotine consumption and dopamine reward signals in the nucleus accumbens |
| Q35184641 | Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior. |
| Q34173418 | Reward, addiction, withdrawal to nicotine |
| Q37106501 | Rodent models of nicotine reward: what do they tell us about tobacco abuse in humans? |
| Q30495752 | Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice |
| Q46309086 | Role of beta2-containing nicotinic acetylcholine receptors in auditory event-related potentials |
| Q50647796 | Role of α4- and α6-containing nicotinic receptors in the acquisition and maintenance of nicotine self-administration. |
| Q35831006 | Role of α7- and β4-containing nicotinic acetylcholine receptors in the affective and somatic aspects of nicotine withdrawal: studies in knockout mice |
| Q36906652 | Role of β4* Nicotinic Acetylcholine Receptors in the Habenulo-Interpeduncular Pathway in Nicotine Reinforcement in Mice. |
| Q37236502 | Sex differences in response to nicotine in C57Bl/6:129SvEv mice |
| Q33552906 | Stimulation of nicotine reward and central cholinergic activity in Sprague-Dawley rats exposed perinatally to a fat-rich diet |
| Q30487079 | Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice. |
| Q42369876 | TC299423, a Novel Agonist for Nicotinic Acetylcholine Receptors |
| Q34953245 | Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence |
| Q92565525 | Targeting the α4β2- and α7-Subtypes of Nicotinic Acetylcholine Receptors for Smoking Cessation Medication Development |
| Q33703839 | The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice |
| Q47073739 | The cytisine derivatives, CC4 and CC26, reduce nicotine-induced conditioned place preference in zebrafish by acting on heteromeric neuronal nicotinic acetylcholine receptors. |
| Q47848449 | The effects of nicotine in the neonatal quinpirole rodent model of psychosis: Neural plasticity mechanisms and nicotinic receptor changes |
| Q37291517 | The endocannabinoid system: a new molecular target for the treatment of tobacco addiction. |
| Q37353755 | The endogenous cannabinoid system modulates nicotine reward and dependence |
| Q34988448 | The necessity of α4* nicotinic receptors in nicotine-driven behaviors: dissociation between reinforcing and motor effects of nicotine |
| Q47550611 | The nicotinic receptor drug sazetidine-A reduces alcohol consumption in mice without affecting concurrent nicotine consumption |
| Q37416390 | The role of alpha6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal |
| Q48221656 | The role of the α7 subunit of the nicotinic acetylcholine receptor in the acute toxicosis of methyllycaconitine in mice |
| Q42600613 | The role of the α7 subunit of the nicotinic acetylcholine receptor on motor coordination in mice treated with methyllycaconitine and anabasine |
| Q40392015 | The α3β4* nicotinic acetylcholine receptor subtype mediates nicotine reward and physical nicotine withdrawal signs independently of the α5 subunit in the mouse |
| Q30442195 | The β2 nicotinic acetylcholine receptor subunit differentially influences ethanol behavioral effects in the mouse |
| Q30479050 | Trace Eyeblink Conditioning is Impaired in α7 but not in β2 Nicotinic Acetylcholine Receptor Knockout Mice |
| Q26852485 | Translational research in nicotine dependence |
| Q36927768 | Treatment for tobacco dependence: effect on brain nicotinic acetylcholine receptor density |
| Q37076206 | Unraveling the neurobiology of nicotine dependence using genetically engineered mice |
| Q36746829 | Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice |
| Q34553486 | Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration |
| Q33551855 | beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking |
| Q30362464 | nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives. |
Search more.